Company intelligence / Profile preview

Geneia

Harrisburg, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Geneia is a healthcare technology and services company that specializes in population health management and data analytics. The company's core offering is the Theon platform, which integrates clinical, claims, and consumer data to provide healthcare payers and providers with actionable insights. These insights are used to improve clinical outcomes, lower costs, and support the transition to value-based care models. Geneia was originally a subsidiary of Capital BlueCross before being acquired by Cedar Gate Technologies in 2022 to enhance their end-to-end value-based care performance management capabilities.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Capital BlueCross

Beyond the preview

Go deeper on Geneia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Geneia.

Explore the full profile